Travere Therapeutics (TVTX) Ownership - Who Owns Travere Therapeutics?

607 Followers

Travere Therapeutics (TVTX) Ownership Overview

1.56% Insiders

36.86% Mutual Funds

0.18% Other Institutional Investors

16.10% ETFs

45.30% Public Companies and

Individual Investors

The ownership structure of Travere Therapeutics (TVTX) stock is a mix of institutional, retail, and individual investors. Approximately 53.14% of the company’s stock is owned by Institutional Investors, 1.56% is owned by Insiders, and 45.30% is owned by Public Companies and Individual Investors.

The ownership structure of Travere Therapeutics (TVTX) stock is a mix of institutional, retail, and individual investors. Approximately 37.04% of the company’s stock is owned by Institutional Investors, 1.56% is owned by Insiders, and 16.10% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$242671
Dec 31, 2025	Hussman Strategic Advisors Inc	xxxxxxxxxxxxx	$1203615
Dec 31, 2025	Fisher Asset Management Llc	xxxxxxxxxxxxx	$1298987
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$6276527

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	9,928,796	Institution	10.76%	304,814,037
	4,588,506	Institution	4.97%	140,867,134
Joseph Edelman	4,278,180	Institution	4.64%	131,340,126
	3,776,277	Institution	4.09%	115,931,704
	3,771,003	Institution	4.09%	115,769,792
	3,329,427	Institution	3.61%	102,213,409
	2,643,377	Institution	2.87%	81,151,674
	2,621,630	Institution	2.84%	80,484,041
	1,434,408	Institution	1.56%	44,036,326
	1,384,751	Institution	1.50%	42,511,856

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
9,928,796	Institution	10.76%	304,814,037
3,776,277	Institution	4.09%	115,931,704
2,643,377	Institution	2.87%	81,151,674
2,621,630	Institution	2.84%	80,484,041
1,434,408	Institution	1.56%	44,036,326
1,384,751	Institution	1.50%	42,511,856
1,256,468	Institution	1.36%	38,573,568
1,178,805	Institution	1.28%	36,189,314
996,678	Institution	1.08%	30,598,015
805,100	Institution	0.87%	24,716,570

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
SPDR S&P BIOTECH ETF	3,169,819	Institution	3.44%	99,659,109
Vanguard Total Stock Market ETF	2,825,830	Institution	3.06%	84,181,476
iShares Russell 2000 ETF	1,948,454	Institution	2.11%	56,427,228
Vanguard Extended Market ETF	976,990	Institution	1.06%	29,104,532
iShares Biotechnology ETF	679,507	Institution	0.74%	19,678,523
iShares Russell 2000 Growth ETF	631,730	Institution	0.68%	18,294,901
Schwab U.S. Small-Cap ETF	433,568	Institution	0.47%	13,631,378
Vanguard Russell 2000 ETF	408,708	Institution	0.44%	12,175,411
Invesco Dynamic Pharmaceuticals ETF	382,289	Institution	0.41%	11,071,089
Vanguard Health Care ETF	255,589	Institution	0.28%	7,613,996

FAQ

Who Owns Travere Therapeutics (TVTX)?

According to the latest TipRanks data, approximately 0.18% of the company's stock is held by institutional investors, 1.56% is held by insiders, and 45.30% is held by retail investors.

What percentage of Travere Therapeutics (TVTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.18% of Travere Therapeutics (TVTX) stock is held by institutional investors.

What percentage of Travere Therapeutics (TVTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 45.30% of Travere Therapeutics (TVTX) stock is held by retail investors.

Who owns the most shares of Travere Therapeutics (TVTX)?

Delaware Group Equity Funds V owns the most shares of Travere Therapeutics (TVTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.